Aligarh

Multiple vacancies in Indian Institute of Toxicology Research - Project Assistants & SRF | Walk in - 13 posts

The Indian Institute of Toxicology Research (IITR), established in 1965, a constituent laboratory of Council of Scientific & Industrial Research (CSIR) engaged in the Research & Development in the areas of Environmental Toxicology, Predictive Toxicology, Health Risk Assessment, Preventive Toxicology, Inhalation Toxicology, Analytical Toxicology, and also National S&T Missions. IITR has two campuses; the main campus is located at the centre of Lucknow City and the other campus at a distance of approx.

TAK-875- A NEWER NOVEL ORAL TREATMENT FOR TYPE-2 DIABETES: A REVIEW

About Authors:
Satyanand tyagi*, Raghvendra1
*President, Tyagi Pharmacy Association & Scientific Writer,
Chattarpur, New Delhi, India-110074.
Prof. Satyanand Tyagi is a life time member of various pharmacy professional bodies like IPA, APTI and IPGA. He has published various research papers and review articles. His academic works include 45 Publications (37 Review Articles and 08 Research Articles of Pharmaceutical, Medicinal and Clinical Importance, published in standard and reputed National and International Pharmacy journals; Out of 45 publications, 10 are International Publications).
1Department of Pharmaceutics, Aligarh College of Pharmacy,
Aligarh, U.P, India-202001.
*sntyagi9@yahoo.com,
+91-9871111375 / 9582025220

ABSTRACT
Tak-875, a new treatment for type-2 diabetes, improves blood sugar control and is equally effective as glimepiride (Sulfonylurea, oral hypoglycaemic agent), but has a significantly lower risk of hypoglycaemia, according to a new study. It works by boosting the release of insulin from pancreatic beta cells when glucose and fatty acids rise in the blood, such as after a meal, which results in a fall in blood glucose levels. TAK-875 is a novel oral medication designed to enhance insulin secretion in a glucose dependent manner, which means that it has no effect on insulin secretion when glucose levels are normal, and as such has the potential to improve the control of blood sugar levels without the risk of hypoglycaemia. The pill belongs to a new class of treatments called GPR40 agonists, which activate a receptor that stimulates and regulates insulin production. New treatments are needed because of “the expected increase in the number of cases of Type 2 diabetes during the next few decades” and because some current drugs have “insufficient effect,” the researchers, led by Charles Burant at the University of Michigan Medical School, wrote in the study. Free fatty acid receptor 1 (FFA1), also known as G protein-coupled receptor 40 (GPR40), plays a vital role in stimulating and regulating the production of insulin. It works by boosting the release of insulin from pancreatic β-cells when glucose and fatty acids rise in the blood, such as after a meal. The release of insulin results in a fall in blood glucose levels. Drugs that activate the FFAR1 receptor have the potential to help diabetics release more insulin and improve control of blood glucose levels. This article gives an overview about this newly introduced drug TAK-875 and its role in treatment for type-2 diabetes.

PREPARATION AND EVALUATION OF BIODEGRADABLE ALBUMIN MICROSPHERES OF DICLOFENAC SODIUM

About Authors:
Renu1*, Shashi Kant2*, Rajendra Yadav3, Amit Kumar Tyagi4
1Faculty of Pharmacy, Shivdan Singh Institute of Technology and Management, Aligarh (U.P)
2Jubilant Chemsys Ltd, Noida,
3Department of Pharmaceutical Sciences, Gurukul Kangri University Haridwar, 
4Department of Chemistry, Meerut College, Meerut (U.P)
*shashi.pharma83@gmail.com

ABSTRACT :
Diclofenac is currently the eighth largest-selling drug and the most frequently used NSAID (Non-steroidal anti-inflammatory drug) in the world, since its introduction in Japan in 1974. Diclofenac is among the better tolerated NSAIDs. Only major adverse effect of Diclofenac is that it causes direct and indirect irritation of the gastrointestinal tract (GIT). To reduce the side effects on gastrointestinal tract (GIT) and to improve therapeutic efficacy of Diclofenac, it can be formulated in polymeric microspheres.
The use of polymeric carriers in formulations of therapeutic drug delivery systems has gained widespread application, due to their advantage of being biodegradable and biocompatible. Among the microparticulate systems, microspheres have a special importance since it is possible to target drugs and provide controlled release. Diclofenac sodium (DS), is a potent drug in the NSAID group having non-steroidal, anti-inflammatory properties, and is widely used in the treatment of rheumatoid arthritis, osteoarthritis and ankylosing spondylitis. In this present study, it was aimed to prepare microsphere formulations of DS using a natural biodegradable polymer as a carrier for administration to extend the duration period of the dosage form. Microsphere formulations of DS which were prepared were evaluated in vitro for particle size, yield value, encapsulation efficiency, surface morphology, and in vitro drug release.

Faculty Posts as Professors/Lecturers in Mangalayatan University - 7 posts

Mangalayatan University (MU) has been created under the "Mangalayatan University, Uttar Pradesh Act" and notified by the Government of Uttar Pradesh as Act No. 32 of 2006, by its Gazette No. 362/VII-V-1-1(Ka)-12/2006 dated October 30, 2006, with the right to confer degrees under section (2f) and 22(1) of the UGC Act.

BIOCATALYSIS IN ORGANIC SOLVENT SYSTEM

About Authors:
Chhavi Bartaria*, Javed Ali Khan
Institute of Biomedical Education and Research,
Mangalayatan University,
Aligarh.

*cbartaria@gmail.com

Abstract
Biocatalysis involving certain enzymes like NHase, Nitrilase, Tannase and Amidase produces certain commercially important compounds .NHase are used for the synthesis of certain compounds such as acrylamide and nicotinamide. Thermostable Nitrilase from the Rhodococcus strains is used for the modification of acrylic fiber surface. The activity of amidase enzymes is five times increased and inhibited with the use of Co2+and Hg2+, 2-mercaptoethanol, dithiothreitol, and ethylene diaminetetraceticacid respectively. Furthermore the production of amidesis done as a by the help of a nitrilase-catalysed reaction of a heterolytic amino nitriles by a enzyme. For the hydrolysis of Gallic acid esters and hydrolysable tannis the tannase is use as catalyst and this gallic acid is produced by the hydrolysis of methyl gallate by fungal tannase, the tannase activity is also shown by lactic acid bacteria and the nitrilase is used for the modification of acrylic fibers by the help of a reaction media with some parameters like time, enzyme activity and its formulation.

Walk in : Systopic Labs invites for post of Trainee Medical Representative | Lucknow, Delhi, Hissar, Aligarh

Systopic is an established pharmaceutical organization with an enterprising field force of 750, we believe in Nurturing Talent & help our people grow. A befitting remuneration package along with one of the best incentive schemes ensures that performers are appropriately rewarded.

Pages